- Type / Class
- Equity / Common Stock
- Shares outstanding
- 93,299,785
- Total 13F shares
- 90,516,772
- Share change
- +3,718,177
- Total reported value
- $213,617,478
- Put/Call ratio
- 45%
- Price per share
- $2.36
- Number of holders
- 121
- Value change
- -$156,957,499
- Number of buys
- 84
- Number of sells
- 56
Quarterly Holders Quick Answers
What is CUSIP 76200L309?
CUSIP 76200L309 identifies RZLT - Rezolute, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76200L309:
Top shareholders of RZLT - Rezolute, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Genexine Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
91,300,933
|
$173,462,643 | — | 26 Apr 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
RA Capital Healthcare Fund, L.P. |
9.9%
|
15,302,186
|
$146,288,898 | $0 | 11 Dec 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
15%
|
14,034,712
|
$131,926,293 | — | 30 Sep 2025 | |
| FMR LLC |
13F
13D/G
|
Company |
2.5%
from 13D/G
|
12,764,233
|
$119,983,791 | — | 30 Sep 2025 | |
| Young-Jin Kim |
3/4/5
|
Director |
—
mixed-class rows
|
8,606,336
mixed-class rows
|
$78,981,947 | +$3,999,999 | 19 Nov 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.4%
from 13D/G
|
5,004,436
|
$47,041,697 | — | 30 Sep 2025 | |
| Opaleye Management Inc. |
13D/G
13F
|
Company |
5.3%
|
4,912,900
|
$46,967,324 | $0 | 12 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
5.2%
|
4,870,000
|
$45,778,000 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.7%
|
4,410,082
|
$41,454,771 | — | 30 Sep 2025 | |
| Blackstone Inc. |
13F
|
Company |
3.2%
|
3,023,899
|
$28,424,651 | — | 30 Sep 2025 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
3.1%
|
2,882,149
|
$27,092,201 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.9%
|
2,728,315
|
$25,646,160 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
2.9%
|
2,695,978
|
$25,342,193 | — | 30 Sep 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.6%
|
2,451,809
|
$23,047,005 | — | 30 Sep 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
2.3%
|
2,112,432
|
$19,856,861 | — | 30 Sep 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
2.3%
|
2,100,000
|
$19,740,000 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.2%
|
2,091,476
|
$19,659,874 | — | 30 Sep 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
2.1%
|
2,000,000
|
$18,800,000 | — | 30 Sep 2025 | |
| CAXTON CORP |
13F
|
Company |
2.1%
|
1,986,818
|
$18,676,089 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2%
|
1,847,384
|
$17,369,547 | — | 30 Sep 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
2%
|
1,822,728
|
$17,133,643 | — | 30 Sep 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
1.9%
|
1,807,202
|
$16,987,698 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13D/G
13F
|
Company |
6.5%
|
6,064,486
|
$14,372,832 | $0 | 31 Dec 2025 | |
| Nantahala Capital Management, LLC |
13D/G
|
— |
4.9%
|
2,857,982
|
$11,317,609 | -$8,350,591 | 31 Dec 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.2%
|
1,157,410
|
$10,879,651 | — | 30 Sep 2025 | |
| HANDOK, INC. |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
5,942,617
|
$10,051,937 | — | 15 Oct 2021 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
938,844
|
$8,825,134 | — | 30 Sep 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.98%
|
917,630
|
$8,625,722 | — | 30 Sep 2025 | |
| 22NW, LP |
13F
|
Company |
0.88%
|
820,653
|
$7,714,138 | — | 30 Sep 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.87%
|
815,975
|
$7,670,165 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.83%
|
772,454
|
$7,261,067 | — | 30 Sep 2025 | |
| Velan Capital Investment Management LP |
13F
|
Company |
0.8%
|
750,000
|
$7,050,000 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.7%
|
652,139
|
$6,130,107 | — | 30 Sep 2025 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
557,411
|
$5,239,663 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.58%
|
541,487
|
$5,089,977 | — | 30 Sep 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.49%
|
452,733
|
$4,255,690 | — | 30 Sep 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.39%
|
363,947
|
$3,421,102 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.39%
|
359,947
|
$3,383,502 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.36%
|
337,920
|
$3,176,447 | — | 30 Sep 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
309,696
|
$2,911,142 | — | 30 Sep 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.33%
|
308,336
|
$2,898,358 | — | 30 Sep 2025 | |
| J. Goldman & Co LP |
13F
|
Company |
0.32%
|
294,259
|
$2,766,035 | — | 30 Sep 2025 | |
| David M. Knott Jr. |
13F
|
Individual |
0.29%
|
275,000
|
$2,585,000 | — | 30 Sep 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.27%
|
251,629
|
$2,365,313 | — | 30 Sep 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.25%
|
233,000
|
$2,190,200 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.24%
|
227,537
|
$2,138,848 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.2%
|
191,261
|
$1,797,853 | — | 30 Sep 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.19%
|
179,272
|
$1,685,157 | — | 30 Sep 2025 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.18%
|
166,055
|
$1,560,917 | — | 30 Sep 2025 | |
| Point72 Europe (London) LLP |
13F
|
Company |
0.14%
|
127,740
|
$1,200,759 | — | 30 Sep 2025 |
Institutional Holders of Rezolute, Inc. - Common Stock (RZLT) as of Q4 2025
As of 31 Dec 2025,
Rezolute, Inc. - Common Stock (RZLT) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,516,772 shares.
The largest 10 holders included
FEDERATED HERMES, INC., RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., Opaleye Management Inc., VANGUARD GROUP INC, Balyasny Asset Management L.P., BANK OF AMERICA CORP /DE/, STATE STREET CORP, UBS Group AG, and Affinity Asset Advisors, LLC.
This page lists
121
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
115
Q4 2025 holders
121
Holder diff
6
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.